secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001217234-25-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q4 revenue $86.6M (+32% YoY), FY2025 guidance $365-375M; $50M buyback
----------------------------------------------------------------------------

- Q4 revenue $86.6M (+32% YoY); testing services revenue $63.8M (+37%); volume ~45,500 tests (+14%).
- Q4 GAAP net income $87.7M ($1.51 diluted EPS) vs loss $118.1M in Q4 2023; non-GAAP net income $10.7M ($0.18).
- Full year revenue $333.8M (+19%); net income $52.5M (incl. $96.3M litigation reversal); adj. EBITDA $27.8M.
- Board authorized $50M stock buyback over up to 24 months. Cash $261M, no debt as of Dec 31, 2024.
- FY2025 revenue guidance $365M-$375M (9-12% growth); CEO cites 'transformative year' and long-term growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000007/0001217234-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000007/cdna-20250226.htm
  HTML page:      https://secwatch.observer/filing/0001217234-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer